Hauache Omar M, Reis André F, Oliveira Carolina S V, Vieira José Gilberto H, Sjöroos Minna, Ilonen Jorma
Escola Paulista de Medicina/UNIFESP, Sao Paulo, SP, Brazil.
Dis Markers. 2005;21(3):139-45. doi: 10.1155/2005/684123.
The study aimed to further characterise HLA encoded risk factors of type 1 diabetes (T1D) in Brazilian population and test the capability of a low resolution full-house DR-DQ typing method to find subjects at diabetes risk. Insulin and CTLA-4 gene polymorphisms were also analysed. The method is based on an initial DQB1 typing supplemented by DQA1 and DR4 subtyping when informative. Increased frequencies of both (DR3)-DQA105-DQB102 and DRB104-DQA103-DQB10302 haplotypes were detected among patients. DRB10401, 0402, 0404 and 0405 alleles were all common in DQB10302 haplotypes and associated with T1D. (DRB111/12/1303)-DQA105-DQB10301, (DRB101/10)-DQB10501, (DRB115)-DQB10602 and (DRB11301)-*0603 haplotypes were significantly decreased among patients. Genotypes with two risk haplotypes or a combination of a susceptibility associated and a neutral haplotype were found in 78 of 126 (61.9%) T1D patients compared to 8 of 75 (10.7%) control subjects (P < 0.0001). Insulin gene -2221 C/T polymorphism was also associated with diabetes risk: CC genotype was found among 83.1% of patients compared to 69.3% of healthy controls (P=0.0369, OR 1.98) but CTLA-4 gene +49 A/G polymorphism did not significantly differ between patients and controls. Despite the diversity of the Brazilian population the screening sensitivity and specificity of the used method for T1D risk was similar to that obtained in Europe.
该研究旨在进一步刻画巴西人群中1型糖尿病(T1D)的HLA编码风险因素,并测试低分辨率全谱DR-DQ分型方法查找糖尿病风险受试者的能力。同时还分析了胰岛素和CTLA-4基因多态性。该方法基于初始的DQB1分型,在信息充分时辅以DQA1和DR4亚型分型。在患者中检测到(DR3)-DQA105-DQB102和DRB104-DQA103-DQB10302单倍型的频率增加。DRB10401、0402、0404和0405等位基因在DQB10302单倍型中均很常见且与T1D相关。(DRB111/12/1303)-DQA105-DQB10301、(DRB101/10)-DQB10501、(DRB115)-DQB10602和(DRB11301)-*0603单倍型在患者中显著减少。在126例T1D患者中有78例(61.9%)发现了具有两种风险单倍型或易感性相关单倍型与中性单倍型组合的基因型,而在75例对照受试者中有8例(10.7%)发现了这种情况(P<0.0001)。胰岛素基因-2221 C/T多态性也与糖尿病风险相关:83.1%的患者为CC基因型,而健康对照中这一比例为69.3%(P=0.0369,比值比1.98),但CTLA-4基因+49 A/G多态性在患者和对照之间无显著差异。尽管巴西人群具有多样性,但所使用的T1D风险筛查方法的敏感性和特异性与在欧洲获得的结果相似。